The National Kidney Foundation issued a statement today urging patients on dialysis to continue undergoing treatments during the COVID-19 pandemic. “It is extremely important for kidney patients to continue with their regularly scheduled dialysis treatments and take extra precautions when visiting the facilities to best protect their health,” said Joseph Vassalotti, MD, Chief Medical Officer for NKF. “Skipping…
In a study of kidney transplant recipients, mean hemoglobin levels rose from 10.69 g/dL prior to transplantation to 14.45 g/dL at 1 year after transplantation.
Women with hypertensive disorders of pregnancy not only appear to have elevated risks for cardiovascular and cerebrovascular disease, but also kidney disease.
Patients starting on peritoneal dialysis or in-center hemodialysis have similar mortality risks, according to a new systematic review and meta-analysis of studies using propensity score matching to compare mortality risks between the modalities.
The study expands on prior research by incorporating a larger more diverse CKD/ESRD population followed over a longer period, and it adjusted for several important confounders, such as kidney transplant status.
Not only do kidney disease patients have higher rates of cardiovascular events, cardiovascular disease events may increase the risk of end-stage renal disease in the general population.
A study of patients with chronic kidney disease found that regular and occasional binge drinkers had double the risk of disease progression compared with non-drinkers.
Increasing levels of fibroblast growth factor 23 in patients with chronic kidney disease are independently associated with an increased risk of requiring maintenance dialysis or a kidney transplant, a study found.
Study shows incidence rate 3 times higher than that seen in general population.
Higher risk for ESKD, death suggests closer monitoring needed, especially in first year after surgery